GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » 3-Year Revenue Growth Rate

Universal Ibogaine (TSXV:IBO) 3-Year Revenue Growth Rate : 0.00% (As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine 3-Year Revenue Growth Rate?

Universal Ibogaine's Revenue per Share for the three months ended in Jan. 2025 was C$0.00.

During the past 12 months, Universal Ibogaine's average Revenue per Share Growth Rate was -45.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Universal Ibogaine's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Universal Ibogaine's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's 3-Year Revenue Growth Rate falls into.


;
;

Universal Ibogaine 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Universal Ibogaine  (TSXV:IBO) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Universal Ibogaine 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Executives
Ian Rabb Senior Officer

Universal Ibogaine Headlines